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Mass spectrometry (MS)-based proteomics provides
a powerful approach to globally investigate the bio-
logical function of individual cell types in mammalian
organs. Here, we applied this technology to the in-
depth analysis of purified hepatic cell types from
mouse. We quantified 11,520 proteins, making this
the most comprehensive proteomic resource of any
organ to date. Global protein copy number determi-
nation demonstrated that a large proportion of the
hepatocyte proteome is dedicated to fatty acid and
xenobiotic metabolism. We identified as-yet-un-
known components of the TGF-b signaling pathway
and extracellular matrix in hepatic stellate cells, un-
covering their regulative role in liver physiology.
Moreover, our high-resolution proteomic data set
enabled us to compare the distinct functional roles
of hepatic cell types in cholesterol flux, cellular traf-
ficking, and growth factor receptor signaling. This
study provides a comprehensive resource for liver
biology and biomedicine.
INTRODUCTION
The liver is the metabolic center of the mammalian body. It is the
largest internal organ with a complex architecture that ensures
the proper interaction of hepatic cell types (HCTs) within the
microenvironment of the liver. HCTs perform wide-ranging bio-
logical functions such as amino acid, fatty acid, and carbohydrate
metabolism; synthesis of bile acids and hormones; lipoprotein
biogenesis; and detoxification (Falco´n-Pe´rez et al., 2010). The
majority of these physiological tasks are carried out by hepato-
cytes (HCs), the hepatic parenchyma that occupies approxi-
mately 90% of liver volume. The remaining, ‘‘nonparenchymal’’
cells (NPCs) are Kupffer cells (KCs), which are hepatic macro-
phages; liver sinusoidal endothelial cells (LSECs), which line the
blood vessels; hepatic stellate or Ito cells (HSCs), which are
involved in liver fibrosis; intrahepatic cholangiocytes (CHCs);
epithelial biliary tree cells; and other rare cell types. The isolation
of HCTswith high purity and quantity is challenging due to several
technical obstacles, including low isolation yield of rare NPCs as
well as controversy over cell-type-specific markers (Elvevold
et al., 2008). In recent years, protocols have been developed to1076 Cell Metabolism 20, 1076–1087, December 2, 2014 ª2014 Elseoptimize the isolation of HCTs (Liu et al., 2011; Maschmeyer
et al., 2011); however, they have not yet been applied to investi-
gate functional specialties of all HCTs in a single study.
Mass spectrometry (MS)-based proteomics provides a unique
and powerful means of investigating proteomic signature of bio-
logical samples in an unbiased manner (Aebersold and Mann,
2003). Difficulties facing proteomic studies of the liver include
the high complexity of the hepatic proteome and the very high
abundance of metabolic enzymes that can preclude coverage
of low abundant proteins. Moreover, the liver contains a large
volume of circulating blood that can dramatically affect prote-
ome coverage and quantification. Early studies were performed
by 2D gel electrophoresis and generally only identified a few
hundred proteins (Iida et al., 2003; Li et al., 2004). Liquid chroma-
tography-tandem mass spectrometry (LC-MS/MS)-based pro-
teomics has been applied to the liver proteome, but such studies
were initially limited to between 2,000 to 3,000 identified proteins
(Shi et al., 2007; Yan et al., 2004). The ‘‘Liverbase,’’ a public data-
base of the Human Proteome Organization (HUPO), summarized
these studies and currently comprises 6,788 proteins of adult
human liver in healthy and altered physiological conditions
(Sun et al., 2010). The essential role of the liver in whole-body
physiology and the relatively easy access to large amounts of he-
patic lysates make it an attractive organ not only for expression
proteomic studies of the homogenized organ but also for subcel-
lular structures (Falco´n-Pe´rez et al., 2010) as well as for the anal-
ysis of posttranslational modifications (Monetti et al., 2011;
Okabe et al., 2009).
Recently, substantial improvements in the entire MS-based
proteomics pipeline, including sample preparation, liquid chro-
matography, and mass spectrometry hardware, as well as data
analysis, have enabled nearly compete proteome coverage of
cell lines (Mann et al., 2013). A recent liver proteomics data
resource contains 7,700 unique UniProt identifications, as well
as many protein variants (Low et al., 2013). Despite progress in
HCTs isolation techniques, proteomics studies of the liver to
date have been restricted to total liver homogenate that is vastly
overshadowed by the proteome of HCs. However, many hepatic
processes, which occur through intercellular signaling crosstalk
mechanisms, cannot be investigated by data obtained from
mixed cell populations (Bohm et al., 2010), necessitating in-
depth and cell-type-resolved proteomic analysis of the liver.
In this study, we obtained highly purified HCTs of murine liver
using a combination of density gradient centrifugation and mag-
netic affinity cell sorting techniques. We subsequently applied
the recently developed ‘‘in-StageTip’’ (iST) sample preparation
method (Kulak et al., 2014) and an advanced LC-MS/MSvier Inc.
Figure 1. Proteomic Analysis of HCTs
Schematic workflow for the cell-type-resolved proteomics of murine liver.
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proteomes of five hepatic cell types. Our results provide a com-
prehensive and quantitative proteomic data source for individual
cell types of a mammalian organ.
RESULTS
In-Depth Quantitative Proteomics of HCTs
To generate a cell-type-resolved proteomic atlas of the mouse
liver, we isolated the five HCTs from male adult murine livers us-
ing a two-step purification approach (Figure 1; Experimental Pro-
cedures). We achieved highly purified populations of HCTs with
values for HCs, KCs, LSECs, HSCs, andCHCs in excess of 99%,
97%, 96.5%, 98%, and 93.5%, respectively (Figure S1 available
online). The purified HCTs and blood-free perfused liver were
processed using the recently published iST method, which dras-
tically reduces sample processing steps by confining lysates to a
single vessel (Kulak et al., 2014). We chose a six-fraction elution
with strong cation exchange (SCX) prefractionation steps to
achieve in-depth proteome coverage with reasonablemeasuring
time and high sensitivity. The entire proteomic experiments were
performed as biological quadruplicates for the HCT proteome
measurements and as biological triplicates for the primary HCs
dedifferentiation experiments (Experimental Procedures). To
further increase proteome coverage, we transferred peptide
identifications from a ‘‘peptide library’’ of three distinct mouse
cell lines (Hepa 1-6, Hep-53.4, and J774.2) using the ‘‘match be-
tween runs’’ feature implemented in MaxQuant (Cox and Mann,
2008). The resulting 27 proteome samples were analyzed by
high-resolution LC-MS/MS using 4 hr gradients on a benchtop
Orbitrap mass spectrometer (Q Exactive), generating 162 mea-
surement runs containing nearly 15 million high-resolution MS/Cell MetabMS spectra. All data files were processed by the MaxQuant
computational environment with >99% confidence at both pro-
tein and peptide levels (false discovery rate [FDR] < 1%) for iden-
tification by the Andromeda search engine (Cox et al., 2011).
Label-free quantification in MaxQuant is based on accurate
detection of eluting peptides as 3D objects in mass to charge ra-
tio (m/z), elution time, and signal intensity space. The peak inten-
sities for the same peptides are compared to each other across
conditions, and variations in mass spectrometric sensitivity be-
tweenmeasurements areminimized by sophisticated normaliza-
tion algorithms (Cox et al., 2014).
In total, we quantified more than 11,520 proteins, creating the
largest and most accurate organ proteomic resource to date
(Figure 2A; Table S1). Of these, 8,338 proteins (72%) were de-
tected in all experiments, revealing that the majority of the prote-
ome is expressed in all cell types (Figure S2A). Our label-free
quantitative data were highly reproducible among the biological
replicates and showed an average Pearson correlation coeffi-
cient of 0.96 (Figure S2B). ANOVA revealed that at least 59%
of quantified proteins were differently expressed between
HCTs (FDR < 0.01; 6,778 proteins; Figure 2B). This demon-
strates that despite the ubiquitous expression of the majority
of the proteome between cell types, there are substantial quan-
titative specializations of individual cell-type proteomes that
enable the execution of the appropriate physiological functions.
One technical advantage of cell-type-specific analysis is the
concomitant reduction in dynamic range. Indeed, we observed
that over 10% of total quantified proteins were uniquely quan-
tified in HCTs, but not in total liver sample (1,230 proteins;
Figure 2B). To analyze and compare the dynamic range of these
proteomes, we used the protein intensities derived from sum-
med peptide intensities and the cumulative protein abundance
of measured samples (Figures 2C, S2C, and S2D; Experimental
Procedures). The broadest proteome dynamic range was found
in HCs and total liver, spanning nearly seven orders of magni-
tude (Figure 2C). The top 100 most abundant proteins in HCs
and total liver are almost identical, and these top 100 proteins
alone comprised over 40% of the mass of the total proteomes
(Figures S2C and S2D), highlighting the wide dynamic range in
protein abundance in the liver proteome. The majority of these
abundant proteins were metabolic enzymes of different biolog-
ical processes, emphasizing the prominent role of liver as the
metabolic center of the body. The entire cell-type-specific prote-
ome of liver can easily be visualized in the MaxQB database
(Schaab et al., 2012).
Comparison of Proteomics and RNASeq Data in Liver
To determine the relationship between transcriptome and pro-
teome for murine liver and to assess the depth reached by our
workflow, we compared our quantitative proteome of liver sam-
ple with a transcriptome obtained by RNA sequencing (Morta-
zavi et al., 2008). We mapped the RNASeq data to 16,589
protein-coding genes based on the UniProt Knowledgebase
(UniProtKB) (Magrane andConsortium, 2011). To estimate abso-
lute protein amounts, we first used iBAQ values, which represent
the protein abundance normalized to the number of theoretically
observable peptides (Schwanha¨usser et al., 2011). A total of
91% of all genes detected by RNASeq and passing the
commonly used cutoff value of RPKM > 1.0 had correspondingolism 20, 1076–1087, December 2, 2014 ª2014 Elsevier Inc. 1077
Figure 2. In-Depth Proteome Coverage of
HCTs
(A) Identified and quantified proteins in different
cell types. Hepa 1-6, Hep-53.4, and J774.2 were
the mouse cell lines that we used for generation of
the peptide library (Experimental Procedures).
(B) Distribution of all quantified proteins (11,520;
black), significantly changed protein among HCTs
(6,778 proteins, ANOVA, FDR < 0.01; red), and
proteins only quantified in HCTs but not liver
(1,230; blue).
(C) Dynamic range of the proteomes of measured
samples, based on raw protein intensities.
(D) Comparison of protein intensities versus
mRNA intensities for total liver.
(E) Comparison of protein copy numbers versus
mRNA copy number for total liver.
(D and E) The color code represents the density of
points in the corresponding region.
(F) Distribution of themRNA (blue) and protein (red)
copy numbers for total liver. The red dashed-lines
indicate the threshold for robust transcription
detection (RPKM > 1.0) (Mortazavi et al., 2008).
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relations between transcriptome and proteome are typically in
the range of 0.4–0.6 (Low et al., 2013; Nagaraj et al., 2011),
implying that proteome variations can only be explained by tran-
script levels to a limited degree (Schwanha¨usser et al., 2011). For
the nearly 8,311 RNA-protein matches (RPKM > 1.0), we ob-
tained a correlation of 0.60 between RNASeq and our iBAQ
values (Pearson correlation coefficient, R = 0.60; Figure 2D).
The correlation was 0.52 when we calculated protein-RNA
copy numbers from the same data sets (R = 0.52; Figure 2E)
on the basis of individual protein intensities (Wisniewski et al.,
2014). These transcriptome-proteome correlations were stron-
ger than the correlations of about 0.43 reported for the liver of
two rat strains (Low et al., 2013). The copy number range of liver
proteins spanned approximately seven orders of magnitude. Re-
flecting the generally lower amounts ofmRNA in tissue, we found
that the reported mRNAs copy numbers (Mortazavi et al., 2008)
were on average approximately 10,000-fold lower than protein
copy numbers (Figure 2F).1078 Cell Metabolism 20, 1076–1087, December 2, 2014 ª2014 Elsevier Inc.Transformation of Primary HCs in
Tissue Culture
Freshly isolated primary HCs undergo
rapid dedifferentiation toward cell line
phenotype in tissue cultures over a period
of days. However, the proteomic trans-
formation associated with this process
has not been investigated in great depth
and never along a time course (Pan
et al., 2009). To investigate this process,
we quantified the proteome of freshly
isolated primary HCs, HCs that we har-
vested from 1-, 3-, and 7-day cultures
as well as the Hepa 1-6 cell line (Figures
3 and S3; Table S2). The experiment
was performed in biological triplicates in
less than 1 week of measuring time, re-sulting in quantification of 10,305 proteins over the course of
transformation. The reproducibility among replicates was high
with an average Pearson correlation coefficient of about 0.99
(Figure S3A). Approximately 35% of the primary HCs proteome
changed significantly over the 7 day time course in tissue culture
(3,427 proteins, t test, p < 0.01; Figure 3A), indicating substantial
proteome remodeling. Interestingly, the dynamic range of the
proteomes as visualized by the iBAQ values gradually con-
tracted toward the range typical of cell lines in an orderly manner
(Figure 3B). Likewise, the proteome correlation between primary
HCs and cultured HCs or Hepa 1-6 cell line showed a progres-
sive decrease in proteome similarities (Figure 3C). The gradual
transformation of primary HCs in cell culture was also clearly
captured by principle component analysis of the proteomes (Fig-
ure 3D). The partners of the complement system, including Com-
plement factor H (CFH), Complement C3 (C3), and Complement
C4-B (C4-B), as well as Asialoglycoprotein receptor proteins 2
(ASGR-2, a subunit of Ashwell-Morell receptor), decreased grad-
ually in tissue culture and in the Hepa 1-6 cell line (Figures S3B).
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cell debris and particles from their microenvironment (Ricklin
and Lambris, 2007; van’t Veer and van der Poll, 2008).
Conversely, we observed a gradual increase in the levels of cyto-
skeletal proteins, Filamin-A, Filamin-C and PDLI7, trafficking
proteins annexin-A2 and A3, as well as Astrocytic phosphopro-
tein PEA-15, which regulated ERK1/2-dependent processes
and H-RAS-mediated cell transformation (Figures S3B) (Sulzma-
ier et al., 2012). These variations in protein levels were mirrored
in the expression of their corresponding mRNAs measured by
RT-PCR, which also served to independently verify the ability
of our proteomic data to capture proteomic variations in target
cells (Figure 3E).
Comparing the Proteome Signatures of HCTs
We investigated the global diversity of HCTs by unsupervised hi-
erarchical clustering of all quantified proteomes. The hierarchical
matrix was divided into twomain groups: one cluster comprising
total liver and HCs and a second cluster of NPCs subdivided into
KCs, a subgroup of HSCs, and a smaller subgroup of LSECs and
CHCs (Figure 4A). This cosegregation was also represented by
principal-component analysis (PCA) of HCTs (Figure S3C). The
high contribution of HCs to the total liver proteome is in agree-
ment with previous studies (Falco´n-Pe´rez et al., 2010) and the
known organization of liver tissue. We next investigated how
the global proteome patterns related to the cell lineages of
HCTs. The clustering and PCA patterns from our data confirmed
the distinctive hematopoietic fate of KCs, while the cosegrega-
tion of HSCs with LSECs suggests a similar mesodermal origin
for both cell types based on their global proteome compositions.
The embryonic lineage of HSCs has been controversial, with an
origin in all three germ layers having been proposed before (Yin
et al., 2013) (Figures 4A and S3C). We filtered our data for gene
and protein annotations that were enriched in the three promi-
nent clusters observed in Figure 4 (Fisher exact, FDR < 0.02 after
Benjamini-Hochberg correction; Figures 4A and 4B; Table S3).
The enrichment of MHC-II and asthma annotations in KCs, resi-
dent macrophages of liver, is in line with their physiological role
in innate immune responses and inhibition of inflammatory cyto-
kine (Thomson and Knolle, 2010). These results demonstrate
that our proteomic resource recapitulates the key physiological
functions of HCTs in an unbiasedmanner and that they can serve
as a valuable data source for future investigations into hepatic
cell type functions.
Cell-Type-Specific Protein Expression in Murine liver
To identify proteins that display cell-type-specific expression
profiles, we filtered our quantitative data for proteins that were
only detected in one cell type or showed at least 30-fold higher
expression levels in one of the HCTs (ANOVA, FDR < 0.01; Fig-
ure 4C; Table S4). We compared our list of HC- and KC-specific
protein candidates by assessing immunostained liver sections in
the Human Protein Atlas (Uhlen et al., 2010) (Figures S4A and
S4B). For example, the S100A9 protein, which has been shown
to promote inflammation and systemic autoimmunity (Loser
et al., 2010), was specifically abundant in KCs and showed a cor-
responding KC-specific immunostaining in liver sections (Fig-
ure S4B). We performed a Fisher exact test for all the proteins
that significantly changed among the HCTs, and as expected,Cell Metabmany metabolic processes were enriched with very significant
p values (Fisher exact, FDR > 0.02; Table S5). We next explored
the contribution of individual HCT to the liver proteome by
comparing the quantified proteomes in each HCT versus total
liver (t test, FDR 0.01 and 0.001) (Figures 4D, 4E, and S4C–
S4E; Table S6). Comparison of the proteome of HCswith the liver
revealed that the few significantly represented proteins in the
liver sample were mostly components of the extracellular matrix,
as expected when comparing homogenized organ to individually
enriched cells (Figure S4E). Conversely, the proteome of the
NPCs contained specific proteins not detected in total liver, con-
firming the importance of cell-type resolution in creating an ac-
curate and complete atlas of this organ.
Comparison of the proteome of HCs (liver parenchyma)
against the median of quantified proteins in all liver NPCs (Fig-
ure S4F; Table S6) provided a detailed picture of the variation
of proteome profiles between parenchymal cells and NPCs of
this organ. For example, a known marker of KCs, a subunit of
macrophage-1 antigen (integrin am) (Larson and Springer,
1990), was significantly represented in NPCs, while the levels
of Ashwell-Morell receptor (consisting of combinations of the
Asialoglycoprotein receptor proteins, ASGR-1 and -2) (van’t
Veer and van der Poll, 2008) was prominent in HCs. In general,
these protein profiles reflect the global organization of pro-
teomes in hepatic parenchymal cells and NPCs, which modulate
metabolic and specialized (patho)physiological processes in the
liver.
Proteomic Functional Hotspots in HCTs
We next sought to mark functional hotspots of HCT proteomes
through estimation of the absolute amount of proteins in all
HCTs (Wisniewski et al., 2014). The three most abundant
proteins in HCs were liver-specific fatty acid binding protein 1
(FABP1), glutathione S-transferase P (GSTP1), and the mito-
chondrial enzyme carbamoyl-phosphate synthase (CPS1),
highlighting the important role of liver parenchyma in fatty acid
metabolism, xenobiotic biodegradation, and urea cycle (Figures
5A–5C). In contrast, the topmost abundant proteins in all hepatic
NPCs were histone core proteins (Table S7A). We also observed
highly abundant proteins that were specific to NPCs and were
known to be involved in specialized cellular functions. For
example, KCs contained high levels of S100A8 and S100A9,
calcium-binding proteins that have been reported to promote
inflammation and autoimmune response via Toll-like receptor 4
signaling (Loser et al., 2010). Components of the cytoskeleton
and actomyosin machinery, including the a-actins, transgelin,
destrin, filamin-A, tropomyosins, and myosins, were highly rep-
resented especially in LSECs. These proteins sense and trans-
ducemechanical forces and support cellular structure and integ-
rity in other endothelial cells, which have to tolerate high
mechanical stress (Tojkander et al., 2012). HSCs were highly en-
riched for specific trafficking proteins, including annexin-2 and
-3; sorting nexin-2, -3, and -5; and Rab-7 and -11, indicating
the importance of specialized intracellular trafficking in HSCs.
Moreover, annexin-A5 and -A4, as well as prothymosin-a and
parathymosin, were specifically abundant in CHCs (Table S7A).
CHCs are the first line of immune defense in the biliary system,
and the expression of prothymosin-a and parathymosin protect
against opportunistic infections in liver (Hannappel and Huff,olism 20, 1076–1087, December 2, 2014 ª2014 Elsevier Inc. 1079
Figure 3. Dedifferentiation of Primary HCs in Tissue Culture
(A) Distribution of all quantified proteins (10,203; black), significantly changing proteins over the dynamic proteome evolution (5,737, ANOVA, FDR < 0.01; red),
and significantly changed primary HC proteins in Hepa1-6 cell line (4,306, t test, p < 0.01; green) and in 7-day cultures of primary HC (3,427, t test, p < 0.01; blue).
(B) Gradual change in the dynamic range of the proteome from freshly isolated primary HCs to primary HCs cultured for 1, 3, and 7 days and to the Hepa 1-6
cell line.
(C) Gradual decrease in proteome similarity during proteome evolution toward cell line behavior. R is the Pearson correlation coefficient. Brown dots indicate
significantly changed primary HC proteins (t test, p < 0.01). Blue dot represents mitochondrial CPS1, which triggers the first enzymatic reaction of the urea cycle.
The expression level of CPS1 was extremely high in primary HCs and decreased dramatically in the Hepa 1-6 cell line.
(legend continued on next page)
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assess the enriched gene and protein annotations in the individ-
ual HCT proteomes (Fisher exact test, FDR < 0.01; Tables
S7A–S7F). We visualized different protein classes enriched in
various abundance quantiles of HCs andHSCs as representative
examples (Figures 5D and 5E). Annotations of basic cellular pro-
cess including the respiratory chain and proteasome core com-
plex were ubiquitous in all HCTs. In contrast, HCs were highly
specialized for the major physiological functions of liver, empha-
sizing their prominent role as hepatic parenchyma. The ‘‘intrafla-
gellar transport particle A’’ and ‘‘anchored to membrane’’ terms
were exclusively enriched in the low-abundance quartile of HCs
and HSCs, respectively. Less is known about the physiological
function of HSCs compared to other HCTs in normal liver (Yin
et al., 2013). We therefore utilized our in-depth quantitative
data to highlight molecular players of ECM assembly, cytoskel-
eton, transforming growth factor b (TGF-b) signaling pathway,
and immune response in HSCs (Figure 5F; Table S8). This illus-
trates the usefulness of our copy number catalog of HCTs for
functional descriptions aswell as their potential for guiding future
studies into liver cell biology.
System-Wide Proteomic Profiling of Biological Process
in Murine Liver
We next sought to globally define the individual physiological
roles of HCTs in the liver tissue from the comparative proteome
profiling data. The liver centrally regulates cholesterol levels in
the body. The protein expression profiles of the cell types indi-
cate that not only HCs but also KCs and CHCs appear to be
involved in cholesterol recycling (Figure 6). The role of CHCs in
cholesterol flux is less appreciated, but it is known that they
play a crucial role in the inhibition of biliary disease and gallstone
formation (Xia et al., 2012). The Ashwell-Morell receptor (consist-
ing of combinations of the Asialoglycoprotein receptor proteins,
ASGR-1 and -2) is highly expressed in liver and is responsible for
rapid clearance of asialoglycoproteins, von Willebrand factor,
and platelets from circulating blood (van’t Veer and van der
Poll, 2008). In agreement with previous studies (Lee et al.,
2009; van’t Veer and van der Poll, 2008), Ashwell receptor is pre-
dominantly expressed in HCs (Figure S5A). Interestingly, the ra-
tio of copy numbers of ASGR1 to ASGR2 was approximately 4:1
in HCs, 5:1 in KCs, and 7:1 in LSECs (Table S7A), suggesting that
the ASGR-1/-1/-2 trimer is not the only oligomeric combination
of Ashwell receptors (van’t Veer and van der Poll, 2008). While
these receptors and peroxisomal proteins are highly expressed
in HCs (Figures S5A and S5B), our data indicates that LSECs,
HSCs, and CHCs more actively participate in caveolae-medi-
ated uptake, clathrin-mediated endocytosis, and membrane
trafficking (Figures S5C–S5F). High expression levels of proteins
involved in clathrin- and caveolae-mediated uptake in CHCs
(Figures S5C and S5D) would facilitate cholesterol transfer
through SR-BI, LDLR and CD36 receptors (Ro¨hrl and Stangl,
2013). Moreover, the internalization of the Ashwell receptor is
coupled to clathrin-mediated endocytosis or transcytosis. The(D) PCA showing that the overall proteomic phenotype smoothly changes during
cells in the first but not the second PCA dimension. Each spot represents one b
(E) RT-PCR for candidate proteins that were significantly changing over the dyna
protein changes (Figure S3B).
Cell Metabhigh expression levels of this machinery in LSECs and KCs could
also actively contribute to the previously reported intravascular
blood clearance of platelets during sepsis (van’t Veer and van
der Poll, 2008).
The Profile of Cell Signaling Receptors in HCTs
To assess the completeness of our data and the potential of the
different HCTs to trigger signaling pathways through cell surface
receptors, we annotated a list of receptor tyrosine kinases,
growth factor (GF) receptors, and their main coreceptors by inte-
grating data from the UniProtKB database and the literature. We
compared this list with our atlas of liver proteins, as well as pro-
teins annotated as hepatic in UniProtKB and a liver RNASeq
analysis (Mortazavi et al., 2008) (Table S9). Of these data sets,
ours had the largest coverage, encompassing 115 receptors,
including 40 not identified in the two other data sets (Figure 7A).
We assessed our quantitative data (Table S1) for the expression
profiles of several well-known GF receptors in HCTs (Figure 7B).
HCs expressed the highest levels of epidermal GF receptors
ErbB1 and ErbB3 (EGFR and HER3), but not ErbB2. We did
not detect TbRIII (b-glycan) receptors in HCs, in agreement
with previous findings in rat (Date et al., 2000; Scheving et al.,
2006). Only HSCs expressed platelet-derived growth factor re-
ceptor alpha (PDGFRA) receptor, and these cells also showed
the highest levels of TGF-b receptors (TbRI to -III), indicating
the diversity of stimuli that can stimulate HSCs (Figure 7B). The
TbRI:TbRII receptor was present in all HCTs, except LSECs,
in which we did not detect expression of TbRI (Figure 7B). As
demonstrated by these examples, our atlas of copy numbers
can be used to illuminate and place constraints on possible
signaling mechanisms in liver cell types.
DISCUSSION
Transcriptomic, proteomic, and metabolomic studies of
mammalian organs have typically been performed on tissue
homogenates, while the few cell-type-specific studies have
generally focused on just a small subset of cell types. Here
we provide the first comprehensive and cell-type-resolved or-
gan proteomic atlas and show how in-depth and quantitative
cataloging of tissue proteomes can directly shed light on func-
tional specialization of the different liver cell types. Further-
more, the deep proteome data provided here can complement
liver metabolomics efforts by making it possible to correlate
changes in metabolites with changes of enzyme levels on a
global scale.
We here achieved a deep and nearly complete proteome
coverage of liver with more than 11,520 identified and quanti-
fied proteins through our recently developed streamlined MS-
based proteomics pipeline (Kulak et al., 2014; Mann et al.,
2013). This proteome coverage is remarkable considering the
complexity of the liver proteome and wide dynamic range of
the liver, particularly of the HCs. Recent reports on human liver
proteome also led to identification of 10,221 and 9,385 ofculturing in the first dimension, whereas the cell line is separated from primary
iological replicate.
mic proteome transformation shows the same dynamics as the corresponding
olism 20, 1076–1087, December 2, 2014 ª2014 Elsevier Inc. 1081
Figure 4. Cell-Type-Specific Expression Profiles of Murine Liver
(A) Unsupervised hierarchical clustering of quantified proteomes. HCs and total liver segregates from NPCs cell types. Numbers above each cell types indicate
the replicates. Numbers indicate enriched clusters of proteins in HCs and liver (1), KCs (2), and HSCs (3).
(B) Enriched annotations for corresponding clusters in Figure 3A (Fisher exact test, FDR < 0.02 after Benjamini-Hochberg correction).
(C) Protein expression profiles of cell-type-specific proteins that were highly expressed in specific HCTs (ANOVA, FDR < 0.01). ‘‘ND’’ indicates ‘‘Not Detected.’’
(D) Proteome comparison between liver and KCs. The red circle indicates integrin am, which forms the CD11b receptor of KCs, a specific KC marker.
(E) Proteome comparison between liver and LSECs. The red circle represents, Stab2, a specific LSECs marker.
(D and E) Gray and violet lines indicate significance thresholds of 0.01 and 0.001, respectively. The color code represents the density of points in the corre-
sponding region.
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homogenates, respectively (Kim et al., 2014). However, these
livers also contained blood, and recently, it has been
concluded that due to poorly identified peptide and low-quality
of spectra, these data overestimate the number of protein and
should be considered with caution (Ezkurdia et al., 2014; Wil-1082 Cell Metabolism 20, 1076–1087, December 2, 2014 ª2014 Elsehelm et al., 2014). The top 100 most abundant proteins in
HCs and the liver alone comprised more than 40% of the total
copies of protein in the proteome (Figure S2C). This is in line
with a study showing that the top 100 mRNAs in liver constitute
approximately 50% of the total transcriptome (Ramsko¨ld et al.,
2009).vier Inc.
Figure 5. Proteomic Functional Hotspots of
HCs
(A–C) A schematic representation of the molecular
functions of top ranking proteins expressed in
HCs. The numbers in yellow circles indicate the
copy number ranks.
(A) Liver fatty-acid-binding protein (FABP-1) is
involved in the trafficking of fatty acids to different
subcellular structures (including mitochondria,
peroxisomes, and endoplasmic reticulum [for lipid
metabolism]), to lipid droplets (for storage), and to
the nucleus for lipid-mediated transcriptional
regulation.
(B) Glutathione S-transferase P1 (GSTP1) cata-
lyzes the conjugation of xenobiotics and carcino-
gens to glutathione that eventually leads to the
production of mercapturic acids and excretion via
urine and bile. GSTP1 also inhibits apoptosis and
oxidative stress in mitochondria.
(C) Mitochondrial CPS1 mediates the detoxifica-
tion of ammonia via the transfer of the ammonia
group in the urea cycle, enabling its excretion into
the blood. This is achieved by the synthesis of
carbamoyl phosphate. Many other proteins of the
urea cycle also showed high expression levels in
HCs.
(D and E) Ranked protein copy numbers in (D) HCs
and (E) HSCs. Proteins were divided to five
abundance quartiles. The top most significantly
enriched annotations in each quartile are indicated
(Fisher exact test, FDR < 0.01 after Benjamini-
Hochberg correction).
(F) The list of proteins with exclusively higher copy
numbers in HSCs. The proteins were grouped
based on their role in different biological process
(Table S8).
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Cell-Type-Resolved Quantitative Liver ProteomicsCalculating protein copy numbers per cell in liver, we found
that, on average, hepatic proteins are 10,000 times more abun-
dant compare to their codingmRNA (Figure 2F). Interestingly this
is somewhat larger than the recently reported protein-mRNA
abundant ratio of 2,800 for NH3T3 cell line (Schwanha¨usser
et al., 2011). This may reflect the fact that dividing cell lines
havemore need formRNA biosynthesis than postmitotic tissues,
which are also likely to express a great abundance of structural
and enzymatic proteins.
The origin of the HSC lineage is controversial, with genetic
studies in cell lines and mice supporting a mesodermal origin
and studies of human fetal liver showing expression of endo-
dermal markers (Yin et al., 2013). On the other hand, there are
reports of a mesenchymal origin from bone-marrow-derived
cells, and an epithelial-mesenchymal transition in injured livers
could contribute to HSCs (Miyata et al., 2008). In line with the
abovementioned genetic studies, the pattern of cosegregationCell Metabolism 20, 1076–1087, Dof HSCs with LSECs in statistical ana-
lyses from our quantitative data supports
amesodermal origin for HSCs (Figures 4A
and S3C).
We explored the contribution of protein
expression of individual HCTs to the total
liver tissue (Figures 4D, 4E, and S4C–
S4E). The proteomic signature of HCTsrepresents the physiological function of each cell type in liver,
and therefore, these results allow molecular dissection of under-
lying biological process in liver. Although we provided the cell-
type-specific proteome signature of liver, we note that distinct
perivenous and periportal hepatic populations exist, which we
have not yet analyzed. If they can be efficiently purified, they
would be an interesting topic for further proteomic studies.
Applying our technology to a dynamic process, we did, how-
ever, already explore the proteome transformation of primary
HCs in culture. The question of how close cell lines are to primary
cells and how the latter transform into cultured states is a gener-
ally important one that has not been addressed before at the
proteomics level. Our 7-day time course data revealed that the
proteome of primary HCs starts adapting to the in vitro micro-
environment as early as 24 hr after isolation from the liver. More-
over, although Hepa 1-6 cell line expressedmany characteristics
of HCs, they lack key metabolic enzymes and showed a poorecember 2, 2014 ª2014 Elsevier Inc. 1083
Figure 6. Cholesterol Flux in the Liver
(A) The expression profiles of HCTs were compared for cell surface receptors that are involved in cholesterol flux. Data are median ± SD. Stars indicate t test
significance (*p < 0.05). ‘‘ND’’ indicates ‘‘Not Detected.’’
(B) Functional contribution of HCTs in cholesterol flux is depicted based on the quantitative data from (A).
(A and B) HCs and KCs displayed higher expression levels of Abca1 and SR-BI, which mediate cholesterol flux with lipoproteins particles (blue stars). Biliary
secretion of cholesterol through Abcg5/Abcg8 dimer was restricted to HCS. Triglyceride uptake through Lpl and Lipc was similar between different cell types;
however, as HCs and LSECs are the most abundant cell type in the liver, they contribute a bigger role in triglyceride uptake. LDL uptake via LDLR, Lrp1, and Lsr
was high in HCs and to a lower extent in CHCs (yellow). KCs showed the highest capacity for the uptake of modified-LDL via Apobr, SR-A, and Olr1. HCs also can
uptake oxidized-LDL via LDLR.
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HCs (R = 0.44; Figure 3C). This further emphasizes that although
cell lines are powerful in vitro systems to study many biological
processes, they can be much different from their corresponding
tissues and fresh primary cells. Importantly, our data makes it
possible to pinpoint at the proteome level which functions are
similar and which are distinct between these cellular states.
We also estimated the copy numbers of the detected proteins
in all cell types using our recently developed proteomic ruler
concept (Wisniewski et al., 2014). This analysis revealed proteo-
mic hotspots of HCTs through the marked quantitative differ-
ences of individual proteins and pathways in the different cell
types. For instance, HCs are known to contain a high number
and density of mitochondria and make up an estimated one fifth
of the cell volume of HCs (Beauvoit et al., 1994). Our data quan-
tify this notion, and we found that 53 out of the top 100 most1084 Cell Metabolism 20, 1076–1087, December 2, 2014 ª2014 Elseabundant proteins in HCs (Figure S2C; 27% of the proteome)
were mitochondrial proteins. The family of fatty-acid-binding
proteins (FABPs) is specialized for different type of lipid re-
sponses in cells (Furuhashi and Hotamisligil, 2008), but their
distinctive role in HCTs remains to be investigated. Interestingly,
while FABP1 was the most abundant protein in HCs, we
observed high levels of FABP4 and FABP5 in the LSECs and
HSCs. The latter two family members were also among the top
10 most abundant proteins in adipocytes (Humphrey et al.,
2013). FABP4 has recently been identified as an adipokine that
can regulate insulin secretion during obesity by signaling to
pancreatic b cells (Wu et al., 2014). Given the important role of
the liver in whole-body metabolic homeostasis, and the recently
identified capacity of the liver to regulate insulin sensitivity by the
secretion of so called ‘‘hepatokines’’ (Misu et al., 2010), it is
intriguing to speculate whether the vast abundance of FABP4vier Inc.
Figure 7. Quantitative Comparison of GF Receptors Levels in HCTs
(A) Venn diagram of identified hepatic GF receptors in this study (blue), RNASeq data from Mortazavi et al. (2008) (RPKM cutoff > 1; red), and the UniProtKB
database (green).
(B) Protein expression profiles of HCTs were compared for EGFR, PDGFR, TGF-b, and VEGFR (median ± SD). Stars indicate t test significances (*p < 0.05). ‘‘ND’’
indicates ‘‘Not Detected.’’
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Cell-Type-Resolved Quantitative Liver Proteomicsin these hepatic cell typesmight also point to a hepatokine role of
this molecule. Therefore, the approach we have applied here is
likely to also prove valuable in the identification of key proteins
in other organs and in the context of disease.
Remarkably, in view of previous concerns about limited
coverage of proteomic data sets, our investigation showed the
most complete coverage of receptor proteins compared to he-
patic proteins of UniProtKB and a liver RNASeq analysis (Morta-
zavi et al., 2008). There were 26 receptors that were exclusively
identified in the liver in UniProtKB and the RNA-seq data.
However, since these are also highly represented in the blood,
plasma, and platelets GeneCards database (Stelzer et al.,
2011), these are likely to represent contamination of liver sam-
ples with blood proteins (Table S9).
The analysis of GF receptors expression in liver explains how
individual HCTs selectively respond to various GF stimulations
(Figure 7; Tables S1 and S9). For example, we detected PDGFRA
receptor only in HSCs, and therefore, our data suggest that only
these cells can display the PDGFRA/A and PDGFRA/B receptor
dimers and respond to PDGF-AA and PDGF-CC GF signals in
the liver (Boor et al., 2007). Since many of these receptors are
involved in cellular crosstalk (Bohm et al., 2010; Taub, 2004),
our quantitative data can contribute to elucidating complex inter-
cellular events at the level of receptors and ligands.
Here we have employed advanced MS-based approaches to
accurately determine the proteomic signatures of HCTs. Under-
standing the proteomic entities of hepatic cell populations im-
proves our knowledge of liver function and has wide applications
in basic research, biotechnology, and clinical diagnosis. Further-
more, our study provides a framework that can nowbe applied to
altered physiological states of this or other organs.EXPERIMENTAL PROCEDURES
Reagents
Peristaltic pump P1 was from GE Healthcare. Cell strainers were from BD Bio-
sciences. Percoll, Collagenase IV, Pronase E, hyaluronidase, and DNase I
were from Sigma (Germany). BSA was from Serva Electrophoresis. TrypLE
was from Life Technologies. Magnetic-activated cell sorting (MACS) large
cell columns, CD11b-, CD146 (LSEC)-, streptavidin- MicroBeads, and FcR
Blocking Reagent were from Miltenyi Biotec. Nycodenz was from Progen Bio-
technik. HCs staining with ASGPR1 was not included in the final version of thisCell Metabmanuscript. The following antibodies were used for flow Cytometry: CD11b-
APC/-FITC, CD146-APC/-FITC, EpCAM-APC/-FITC, and EpCAM-Biotin
(Miltenyi Biotec); F4/80-Alex448 and all of the isotype Controls were from
eBioscience. Hep-53.4 and J774.2 cell lines were purchased from Cell Lines
Service (CLS, Germany). RT-PCRwas performed according to manufacturer’s
guidelines (Supplemental Experimental Procedures).
Liver Perfusion and Isolation of HCTs
Male C57BL/6J mice (8–10 weeks old) were used for the isolation of HCTs.
Mice were treated in accordance with approved protocol by Animal Protection
Institute of Upper Bavaria (license number 2532.3-32-12). HCTs were isolated
with different protocols according to their particular density and immunogenic
properties (Figure 1A; Supplemental Experimental Procedures). The isolation
of HCTs and their MS analysis were performed in quadruplicates (four inde-
pendent biological replicates). The proteome comparison of freshly isolated
HC versus Hepa 1-6 cell line and cultured primary HCs were performed in bio-
logical triplicates. For each biological replicate, three to five livers were used.
Sample Preparation for MS analysis
Cell lysis, protein digestion, and peptide fractionation were performed as pre-
viously described (Kulak et al., 2014). Briefly, samples were homogenized and
lysed in StageTips with guanidinium hydrochloride buffer. Proteins were di-
gested with Trypsin and Lys-C at 37C overnight, and the resulting peptides
were fractionated by SCX with six fractions for each SCX experiment. Hepa
1-6, Hep-53.4, and J774.2 cell lines were analyzed in parallel to generate a
‘‘peptide library’’ through the transfer of peptide identifications between mea-
surements using the ‘‘match between runs’’ feature implemented in MaxQuant
(Cox and Mann, 2008). The cell lines and primary HC were cultured in Dulbec-
co’s modified Eagle’s medium, supplemented with 10% FCS, 100 U/ml peni-
cillin, and 100 ug/ml streptomycin. The collagen-coated plates were used for
cell culture of primary HCs. Cells were harvested from about 80% confluent
cultures using trypsin/EDTA and washed with PBS.
LC-MS/MS Analysis
Chromatographic peptide separation was performed with 50 cm columns
packed in-house with ReproSil-Pur C18-AQ 1.9 mm resin (Dr. Maisch
GmbH). Column temperature wasmaintained at 50C by a homemade column
oven. Peptide mixtures were analyzed by a Q-Exactive mass spectrometer
(Thermo Fisher Scientific) coupled to an EASY-nLC 1000 UHPLC system
(Thermo Fisher Scientific) via a nanoelectrospray ion source. Peptides were
loaded in buffer A (0.1% formic acid) and eluted with a 240 min gradient of
5%–60% buffer B (80% acetonitrile and 0.1% Formic acid). MS data were ob-
tained by one full scan and up to five data-dependent MS/MS scans. The full-
scan MS spectra (300 to 1,750 m/z) were acquired with a resolution of 70,000
at m/z 200, a maximum injection time of 20 ms, and a target value of 3 3 106
charges. The precursors were isolated from a 2.2 m/z window, fixed first mass
of 100 m/z, and fragmented by higher energy collisional dissociation (collisionolism 20, 1076–1087, December 2, 2014 ª2014 Elsevier Inc. 1085
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Cell-Type-Resolved Quantitative Liver Proteomicsenergy 25). MS/MS spectra were acquired with a resolution of 17,500 at m/z
200, a maximum injection time of 120 ms, and a target value of 1e5 charges.
Data Analysis
Raw MS data (162 files) were processed by MaxQuant (1.4.1.4) with FDR <
0.01 at the level of both proteins and peptides (Cox andMann, 2008). Peak lists
were searched against the Mouse UniProt FASTA database (2/25/2012) con-
taining 54,232 entries. Proteins and peptides (minimum seven amino acids)
were identified using a target-decoy approach with a reversed database.
Quantification of peptides and proteins was performed by MaxQuant with
default settings. Bioinformatics analysis was performed with Perseus, Micro-
soft Excel, and R statistical computing software. Data and error bars are
median ± SD. All annotations were extracted from UniProtKB. Categorical an-
notations were gene ontology (GO) biological process (BP), molecular function
(MF), cellular component (CC), and KEGG pathway databases.ACCESSION NUMBERS
All raw data and the MaxQuant output tables have been deposited to proteo-
meXchange (Vizcaı´no et al., 2013) and can be accessed with the accession
PXD000867. Please visit http://www.ebi.ac.uk/pride/archive/projects/
PXD000867 to access the data.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, nine tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.cmet.2014.11.002.
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